Subscribe To
Anaptys announces participation in november investor conferences
SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative ...
November 1, 2023, 9:15 am
Outlook therapeutics® to present at guggenheim's 5th annual inflammation, neurology & immunology (ini) conference
Live audio webcast fireside chat on Tuesday, November 7th at 1:50 PM ET Live audio webcast fireside chat on Tuesday, November 7th at 1:50 PM ET...
November 1, 2023, 8:05 am
Aptevo to present at bio-europe conference
SEATTLE, WA / ACCESSWIRE / November 1, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing nov...
November 1, 2023, 7:45 am
Affimed to participate in upcoming investor conferences
MANNHEIM, Germany, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage ...
November 1, 2023, 6:30 am
Scancell melanoma trial data chosen for poster presentation at sitc
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) told investors that it has been selected for a poster presentation of data from the first stage of its Pha...
November 1, 2023, 4:16 am
Astrazeneca inks gene editing deal that could end up costing it $2.5bn
AstraZeneca PLC (LSE:AZN) has entered into a partnership and investment deal with French gene editing specialist biotech firm Cellectis (NASDAQ:CLLS) ...
November 1, 2023, 3:59 am
Poolbeg investor meeting will take a deep dive into lead programme
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) is hosting an investor and analyst meeting focusing on its POLB 001 Oncology Programme, targeting cytokin...
November 1, 2023, 3:34 am
Argenx to present at upcoming investor conferences
November 1, 2023 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology c...
November 1, 2023, 2:00 am
Analyzing the acquisition potential of immunogen
immunoGen, Inc.'s marketing authorization application for ELAHERE, a cancer therapy, has been accepted ...
October 31, 2023, 3:25 pm
Xilio to host virtual investor conference call and webcast on monday, november 6, 2023 to review progress across pipeline, including phase 1/2 clinical data for xtx202, a tumor-activated, engineered,
WALTHAM, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and devel...
October 31, 2023, 9:15 am
Iovance biotherapeutics to present clinical and pre-clinical data for tumor infiltrating lymphocyte (til) therapies at society for tumor immunotherapy of cancer's (sitc) 38th annual meeting
SAN CARLOS, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, dev...
October 31, 2023, 9:05 am
Scancell makes strong progress with lead immunotherapy assets
Key highlights for biotech group Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF)'s financial year ending April 30 included a positive data reading arising...
October 31, 2023, 4:48 am
immunocore to present at upcoming investor conferences
immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & RO...
October 30, 2023, 4:30 pm
Why is medicenna therapeutics (mdna) stock down today?
Medicenna Therapeutics (NASDAQ: MDNA ) stock is falling on Monday after the immunotherapy company aler...
October 30, 2023, 9:29 am
Why abbvie stock fell today
AbbVie stock fell today despite easily exceeding estimates for its third quarter. Revenue declines across AbbVie's ...
October 27, 2023, 3:06 pm
Carisma to present first results from in vivo car-m collaboration with moderna at sitc 2023
-Late-breaking abstract to be presented on November 3 rd at 11:30 am PT highlighting pre-clinical data with Moderna -Two additional pre-clinical data ...
October 25, 2023, 9:11 am
Sensei biotherapeutics to present initial clinical data from dose escalation trial of sns-101 at 2023 sitc annual meeting
BOSTON, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno...
October 25, 2023, 9:05 am
Fate therapeutics to webcast conference call reporting third quarter 2023 financial results
SAN DIEGO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage ...
October 25, 2023, 8:00 am
Argenx to report third quarter 2023 financial results and business update on october 31, 2023
October 24, 2023 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology c...
October 24, 2023, 1:00 am
Harpoon therapeutics stock soars on ‘promising' lung cancer drug results
Harpoon Therapeutics Inc shares surged as much as 40% in pre-market trading on Monday after the clinical-stage ...
October 23, 2023, 9:32 am